News | June 25, 2025
Bachem expands multi-site production capacities to meet rising demand
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Changhua site meets international regulatory standards for global medical applications
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
The transaction is expected to close in Q2 FY 2026
UFlex is the first and only Indian company to receive USFDA approval for its technology and capacity to recycle all three materials
The inspection concluded successfully, with the facility found to be in compliance with the required regulations
The collaboration furthers AstraZeneca’s presence in China following the $2.5bn investment in Beijing
Prasinezumab is a potential first-in-class anti-alpha-synuclein antibody, targeting a known biological driver of Parkinson’s disease progression
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
Subscribe To Our Newsletter & Stay Updated
